In pancreatic cancer and advanced gastric cancer, HHLA2 expression is associated with a better patient prognosis (220, 221); however, some studies suggest no correlation between HHLA2 expression and prognosis in pancreatic cancer patients (222). This evidence concerns the gene HHLA2 and familial pancreatic carcinoma.